Efficacy and safety of the cathepsin K inhibitor, ONO-5334, and alendronate on post-menopausal osteopenia or osteoporosis: 2-year results from ocean study

R. Eastell, S. Nagase, S. Boonen, T. Spector, M. Small, T. Kuwayama, J. Sawyer, S. Deacon

Research output: Contribution to journalMeeting abstract

Original languageEnglish
Pages (from-to)S92 - S93
JournalBone
Volume48
DOIs
Publication statusPublished - 2011

Cite this